Pluristem Therapeutics Operating Expenses 2011-2026 | PSTI

Annual Operating Expenses Pluristem Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	29.5 M	35.6 M	33.8 M	28 M	26.1 M	25.6 M	28.2 M	22.9 M	15.7 M	11.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
35.6 M	11.1 M	25.7 M

Quarterly Operating Expenses Pluristem Therapeutics

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.95 M	-	-	-	4.38 M	4.07 M	4.84 M	2.35 M	4.49 M	3.84 M	2.7 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.95 M	2.35 M	3.95 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.85	3.22 %	$ 9.26 B	Australia
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	1.13 B	$ 327.75	-1.69 %	$ 42.9 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Aligos Therapeutics ALGS	90.2 M	$ 7.65	3.1 %	$ 75.6 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Burford Capital Limited BUR	106 M	$ 4.68	-0.95 %	$ 756 M	Britain
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Cabaletta Bio CABA	172 M	$ 3.44	1.03 %	$ 346 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 21.62	-0.28 %	$ 1.01 B	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
BioNTech SE BNTX	512 M	$ 99.29	-0.18 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.1	-4.32 %	$ 5.1 M	Israel
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	64.6 M	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	173 M	$ 1.41	-9.03 %	$ 363 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.36	-7.81 %	$ 151 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	85.5 M	$ 4.18	-1.5 %	$ 447 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 24.23	-1.42 %	$ 3.08 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Grifols, S.A. GRFS	1.64 B	$ 8.68	-0.12 %	$ 6.83 B	Spain
Autolus Therapeutics plc AUTL	145 M	$ 1.48	-0.67 %	$ 394 M	Britain
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	33.1 M	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 33.44	-1.27 %	$ 2.22 B	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA